"The Once A Day Protease Inhibitor Regimens"
NCT00242216
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
76
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
ritonavir-boosted atazanavir
DRUG:
ritonavir-boosted fosamprenavir
Sponsor
The University of Texas Health Science Center, Houston